Screenshot 2018-10-08 at 5.23.34 PM.png
Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
December 15, 2020 07:55 ET | Karamedica, Inc.
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...
Screenshot 2018-10-08 at 5.23.34 PM.png
Karamedica Announces National Institute of Aging Grant to Develop Microparticle Therapy for Cerebral Amyloid Angiopathy (CAA)
October 10, 2018 08:00 ET | Karamedica, Inc.
RALEIGH, N.C., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Karamedica, Inc., a start-up biomedical company, recently received a Small Business Innovative Research (SBIR) grant from the National Institute of...